novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

2016 European Guidelines on cardiovascular disease prevention in clinical practice

26 Maio 2016

guidelines-europeias
esc2016-guidelines02 esc2016-guidelines03 esc2016-guidelines04 esc2016-guidelines05 esc2016-guidelines06 esc2016-guidelines07

Heart Failure Congress 2016 Guidelines

23 Maio 2016
0

DISGEN-LIPID Resultados

31 Maio 2016
0

-->